![GALYM IMANBAYEV](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
GALYM IMANBAYEV
Director/Miembro de la Junta en Kirilys Therapeutics, Inc. .
Cargos activos de GALYM IMANBAYEV
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Lightspeed Management Co LLC
![]() Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Inversor de Capital Privado | 01/01/2020 | - |
Kirilys Therapeutics, Inc.
![]() Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Historial de carrera de GALYM IMANBAYEV
Formación de GALYM IMANBAYEV.
Stanford University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectorial
Finance | 2 |
Consumer Services | 2 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Lightspeed Management Co LLC
![]() Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Finance |
Kirilys Therapeutics, Inc.
![]() Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Health Services |
- Bolsa de valores
- Insiders
- GALYM IMANBAYEV
- Experiencia